Cargando…

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein

The small hydrophobic (SH) glycoprotein of human respiratory syncytial virus (RSV) is a transmembrane protein that is poorly accessible by antibodies on the virion but has an ectodomain (SHe) that is accessible and expressed on infected cells. The SHe from RSV strain A has been formulated in DPX, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torrey, Heather L., Kaliaperumal, Valarmathy, Bramhecha, Yogesh, Weir, Genevieve M., Falsey, Ann R., Walsh, Edward E., Langley, Joanne M., Schepens, Bert, Saelens, Xavier, Stanford, Marianne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553696/ https://www.ncbi.nlm.nih.gov/pubmed/32530723 http://dx.doi.org/10.1080/21645515.2020.1756671

Ejemplares similares

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study
por: Langley, Joanne M, et al.
Publicado: (2018)

Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses
por: Sedeyn, Koen, et al.
Publicado: (2019)

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
por: MacDonald, Lisa D., et al.
Publicado: (2017)

Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial
por: Dorigo, Oliver, et al.
Publicado: (2023)

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
por: Schepens, Bert, et al.
Publicado: (2014)

IgG3 Snitcher of RSV Infections in the Very Young
por: Schepens, Bert, et al.
Publicado: (2017)

Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization
por: Leemans, Annelies, et al.
Publicado: (2018)

Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)

An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25
por: Van Royen, Tessa, et al.
Publicado: (2022)

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Single-Domain Antibodies and Their Formatting to Combat Viral Infections
por: De Vlieger, Dorien, et al.
Publicado: (2018)

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
por: Van Royen, Tessa, et al.
Publicado: (2022)

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
por: Kolpe, Annasaheb, et al.
Publicado: (2019)

Potential resurgence of respiratory syncytial virus in Canada
por: Lavoie, Pascal M., et al.
Publicado: (2021)

The Effect of Steroid Use in Hospitalized Adults With Respiratory Syncytial Virus-Related Illness
por: Lee, F. Eun-Hyung, et al.
Publicado: (2011)

Possible résurgence du virus respiratoire syncytial au Canada
por: Lavoie, Pascal M., et al.
Publicado: (2021)

Respiratory syncytial virus–associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure
por: Falsey, Ann R, et al.
Publicado: (2018)

Respiratory syncytial virus - associated intensive care unit admission in children in Southern China
por: Zhang, Qingli, et al.
Publicado: (2013)

Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model
por: Dirk, Brennan S., et al.
Publicado: (2021)

Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ
por: Jacobs, Sophie, et al.
Publicado: (2018)

Clinical impact of healthcare-associated respiratory syncytial virus in hospitalized adults
por: Hill-Ricciuti, Alexandra, et al.
Publicado: (2023)

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies
por: Schotsaert, Michael, et al.
Publicado: (2016)

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
por: Joe, Patrick Tjok, et al.
Publicado: (2019)

733. Incidence and Evaluation of the Change in Functional Status Associated with Respiratory Syncytial Virus Infection in Hospitalized Older Adults
por: Branche, Angela, et al.
Publicado: (2018)

Variability analysis and inter-genotype comparison of human respiratory syncytial virus small hydrophobic gene
por: Ivancic-Jelecki, Jelena, et al.
Publicado: (2018)

Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019
por: Choi, Yoonyoung, et al.
Publicado: (2021)

Hydrophilic But Not Hydrophobic Surfactant Protein Genetic Variants Are Associated With Severe Acute Respiratory Syncytial Virus Infection in Children
por: Depicolzuane, Lynnlee C., et al.
Publicado: (2022)

796. Burden of Healthcare-associated (HA) Respiratory Syncytial Virus (RSV) in Hospitalized Adults
por: Hill-Ricciuti, Alexandra C, et al.
Publicado: (2021)

415. Airway Gene-Expression Classifiers for Respiratory Syncytial Virus (RSV) Disease Severity in Infants
por: Caserta, Mary T, et al.
Publicado: (2019)

Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide
por: Weir, Genevieve M., et al.
Publicado: (2016)

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
por: Kim, Yae-Jean, et al.
Publicado: (2014)

92. Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017–2019
por: Branche, Angela, et al.
Publicado: (2019)

A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody
por: De Baets, Sarah, et al.
Publicado: (2015)

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
por: Van den Hoecke, Silvie, et al.
Publicado: (2021)

Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
por: Wang, Lu, et al.
Publicado: (2021)

M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A
por: Ibañez, Lorena Itatí, et al.
Publicado: (2013)

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
por: Van Hoecke, Lien, et al.
Publicado: (2020)

Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection
por: De Vlieger, Dorien, et al.
Publicado: (2019)

Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability
por: Carter, Stephen D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hivpu3ddjc8f3jih38vagso8vb